Pegah Ghiabi

1.3k total citations
16 papers, 796 citations indexed

About

Pegah Ghiabi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Pegah Ghiabi has authored 16 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Pegah Ghiabi's work include Cancer, Hypoxia, and Metabolism (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Cancer Cells and Metastasis (3 papers). Pegah Ghiabi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Cancer Cells and Metastasis (3 papers). Pegah Ghiabi collaborates with scholars based in Canada, United States and Qatar. Pegah Ghiabi's co-authors include Shahin Rafii, Arash Rafii, Jennifer Pasquier, Mahtab Maleki, Nadine Abu-Kaoud, Bella S. Guerrouahen, Hamda Al Thawadi, Frank Le Foll, Ludovic Galas and Massoud Mirshahi and has published in prestigious journals such as PLoS ONE, Geochimica et Cosmochimica Acta and Biochemistry.

In The Last Decade

Pegah Ghiabi

16 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pegah Ghiabi Canada 12 482 207 189 90 87 16 796
Apostolos Dimitromanolakis Canada 24 628 1.3× 230 1.1× 308 1.6× 95 1.1× 57 0.7× 37 1.4k
Kristoffer Weber Germany 13 717 1.5× 155 0.7× 436 2.3× 122 1.4× 46 0.5× 17 1.1k
Alka A. Potdar United States 14 480 1.0× 111 0.5× 74 0.4× 94 1.0× 39 0.4× 27 736
Andrea Viale Italy 13 957 2.0× 292 1.4× 361 1.9× 136 1.5× 45 0.5× 19 1.3k
Flora Cimmino Italy 20 511 1.1× 370 1.8× 233 1.2× 70 0.8× 90 1.0× 33 1.1k
Stefania Berton Italy 16 400 0.8× 265 1.3× 405 2.1× 79 0.9× 28 0.3× 28 858
Svetlana A. Mikheeva United States 14 678 1.4× 214 1.0× 258 1.4× 115 1.3× 23 0.3× 22 1.0k
Alexei L. Krasnoselsky United States 13 591 1.2× 159 0.8× 153 0.8× 168 1.9× 29 0.3× 15 1.0k
Vladimir Ignatchenko Canada 24 1.0k 2.2× 320 1.5× 153 0.8× 120 1.3× 74 0.9× 44 1.5k
Georgina P. Coló Argentina 16 406 0.8× 120 0.6× 189 1.0× 114 1.3× 42 0.5× 24 761

Countries citing papers authored by Pegah Ghiabi

Since Specialization
Citations

This map shows the geographic impact of Pegah Ghiabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pegah Ghiabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pegah Ghiabi more than expected).

Fields of papers citing papers by Pegah Ghiabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pegah Ghiabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pegah Ghiabi. The network helps show where Pegah Ghiabi may publish in the future.

Co-authorship network of co-authors of Pegah Ghiabi

This figure shows the co-authorship network connecting the top 25 collaborators of Pegah Ghiabi. A scholar is included among the top collaborators of Pegah Ghiabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pegah Ghiabi. Pegah Ghiabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Eguida, Merveille, Guillaume Bret, Fengling Li, et al.. (2024). Subpocket Similarity-Based Hit Identification for Challenging Targets: Application to the WDR Domain of LRRK2. Journal of Chemical Information and Modeling. 64(13). 5344–5355. 4 indexed citations
2.
Ahmad, Shabbir, Mark Mabanglo, Levon Halabelian, et al.. (2024). Development of Peptide Displacement Assays to Screen for Antagonists of DDB1 Interactions. Biochemistry. 63(10). 1297–1306. 2 indexed citations
3.
Kimani, Serah, Sumera Perveen, Hong Zeng, et al.. (2023). The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition. Communications Biology. 6(1). 1272–1272. 12 indexed citations
4.
Ghiabi, Pegah, et al.. (2023). Discovery of Nedd4 auto-ubiquitination inhibitors. Scientific Reports. 13(1). 16057–16057. 5 indexed citations
5.
Li, Fengling, Pegah Ghiabi, Taraneh Hajian, et al.. (2023). SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(4). 130319–130319. 15 indexed citations
6.
Devkota, Kanchan, Matthieu Schapira, Sumera Perveen, et al.. (2021). Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors. SLAS DISCOVERY. 26(9). 1200–1211. 55 indexed citations
7.
Yazdi, Aliakbar Khalili, Fengling Li, Kanchan Devkota, et al.. (2021). A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex. SLAS DISCOVERY. 26(6). 757–765. 18 indexed citations
8.
Perveen, Sumera, Aliakbar Khalili Yazdi, Kanchan Devkota, et al.. (2021). A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19. SLAS DISCOVERY. 26(5). 620–627. 22 indexed citations
9.
Pasquier, Jennifer, et al.. (2020). Angiocrine endothelium: from physiology to cancer. Journal of Translational Medicine. 18(1). 52–52. 51 indexed citations
10.
Ghiabi, Pegah, Jie Jiang, Jennifer Pasquier, et al.. (2015). Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche. Journal of Translational Medicine. 13(1). 27–27. 46 indexed citations
11.
Guerrouahen, Bella S., Jennifer Pasquier, Mahtab Maleki, et al.. (2014). Akt-Activated Endothelium Constitutes the Niche for Residual Disease and Resistance to Bevacizumab in Ovarian Cancer. Molecular Cancer Therapeutics. 13(12). 3123–3136. 30 indexed citations
12.
Ghiabi, Pegah, Jie Jiang, Jennifer Pasquier, et al.. (2014). Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties. PLoS ONE. 9(11). e112424–e112424. 67 indexed citations
13.
Pasquier, Jennifer, Hamda Al Thawadi, Pegah Ghiabi, et al.. (2014). Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation. Cancer Microenvironment. 7(1-2). 41–59. 46 indexed citations
14.
Pasquier, Jennifer, Bella S. Guerrouahen, Hamda Al Thawadi, et al.. (2013). Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. Journal of Translational Medicine. 11(1). 94–94. 373 indexed citations
15.
Pasquier, Jennifer, Bella S. Guerrouahen, Pegah Ghiabi, et al.. (2012). Tunneling nanotubes mediate preferential transfer of mitochondria from endothelial to cancer cells and confer chemoresistance. 1 indexed citations
16.
Vali, Hojatollah, Marc D. McKee, Neva Çiftçioğlu, et al.. (2001). Nanoforms: a new type of protein-associated mineralization. Geochimica et Cosmochimica Acta. 65(1). 63–74. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026